<p>(A-B) Stable expression of influenza A virus minigenome transcription/replication system in A549-5Ps cells. A549 and A549-5Ps cells were seeded in 6-well plates and cultured for 48 hours. (A) Gluc activity in supernatants was quantified. (B) Total cellular RNAs were extracted and then subjected to RT-PCR using primer pairs specific for PB2, PB1, NP and model vRNA. (C) Relative Gluc activity over a 96-hour time course at different A549-5Ps cell numbers. A549 and A549-5Ps cells were seeded in 96-well plates (5,000/well, 10,000/well, 20,000/well) and supernatants were harvested at different time points, followed by Gluc activity measurement. Error bars standard error of the mean of three independent experiments.</p
<p>P815 cells were mock-treated or infected with the three subtypes of influenza viruses at an equal...
<p>A549 cells were reverse transfected with 50 nM of a non-target negative control siRNA (siNEG) or ...
<p>(A) and (B) A549 cells were transfected with non-targeting or NS1-BP siRNAs for 48 h and infected...
<p>(A-B) Inhibitory effects of amantadine hydrochloride, oseltamivir phosphate and ribavirin. A549-5...
<p>A549-5Ps cells were transfected with 10nM negative control siRNA (NC), Tat-SF1 siRNA and cyclinT1...
For design and optimization of influenza virus production in mammalian cells details on human influe...
<p>A549-5Ps cells were transfected with 30nM negative control siRNA (NC), PB1 siRNA, PB2 siRNA and i...
<p>(A) Schematic representation of Gluc/Bsd reporter system. Gluc/Bsd reporter construct comprises G...
<p>(A) MDCK and BEAS-2B cells were infected with USSR H1N1 or H2N3 influenza viruses at 1.0 MOI (bas...
<p>(<b>A</b>) A549 cells were treated with 5′pppRNA (10 ng/ml); at 24 h post-treatment, cells were i...
<p>A549 cells were transfected with non-targeting or hnRNP K siRNAs for 48 h prior to infection. siR...
<p>(A) Quantification of vRNA and mRNA in infected cells. Six hours after MDCK infection with rescue...
To better understand influenza virus replication dynamics in vaccine production using adherent mamma...
<p>(A) A panel of 33 siRNAs was assayed for viral protein accumulation and infectious particle produ...
(A) A549 cells were infected with influenza A/WSN/33 (H1N1) virus (WSN) or (B) influenza A/PR/8/34 (...
<p>P815 cells were mock-treated or infected with the three subtypes of influenza viruses at an equal...
<p>A549 cells were reverse transfected with 50 nM of a non-target negative control siRNA (siNEG) or ...
<p>(A) and (B) A549 cells were transfected with non-targeting or NS1-BP siRNAs for 48 h and infected...
<p>(A-B) Inhibitory effects of amantadine hydrochloride, oseltamivir phosphate and ribavirin. A549-5...
<p>A549-5Ps cells were transfected with 10nM negative control siRNA (NC), Tat-SF1 siRNA and cyclinT1...
For design and optimization of influenza virus production in mammalian cells details on human influe...
<p>A549-5Ps cells were transfected with 30nM negative control siRNA (NC), PB1 siRNA, PB2 siRNA and i...
<p>(A) Schematic representation of Gluc/Bsd reporter system. Gluc/Bsd reporter construct comprises G...
<p>(A) MDCK and BEAS-2B cells were infected with USSR H1N1 or H2N3 influenza viruses at 1.0 MOI (bas...
<p>(<b>A</b>) A549 cells were treated with 5′pppRNA (10 ng/ml); at 24 h post-treatment, cells were i...
<p>A549 cells were transfected with non-targeting or hnRNP K siRNAs for 48 h prior to infection. siR...
<p>(A) Quantification of vRNA and mRNA in infected cells. Six hours after MDCK infection with rescue...
To better understand influenza virus replication dynamics in vaccine production using adherent mamma...
<p>(A) A panel of 33 siRNAs was assayed for viral protein accumulation and infectious particle produ...
(A) A549 cells were infected with influenza A/WSN/33 (H1N1) virus (WSN) or (B) influenza A/PR/8/34 (...
<p>P815 cells were mock-treated or infected with the three subtypes of influenza viruses at an equal...
<p>A549 cells were reverse transfected with 50 nM of a non-target negative control siRNA (siNEG) or ...
<p>(A) and (B) A549 cells were transfected with non-targeting or NS1-BP siRNAs for 48 h and infected...